These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21621157)

  • 1. It is a tough "ACT" to follow.
    Jobes DR
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):393-4. PubMed ID: 21621157
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of activated coagulation time in children: evaluation of the blood-saving kaolin i-STAT activated coagulation time technique in pediatric cardiac anesthesia.
    Ulmer FF; Baulig W; Béttex D; Spielmann N; Bürki C; Weiss M
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):395-401. PubMed ID: 21376632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standards of monitoring.
    Feneck RO
    J Cardiothorac Vasc Anesth; 1994 Aug; 8(4):379-81. PubMed ID: 7948790
    [No Abstract]   [Full Text] [Related]  

  • 4. [Guidelines for certification of Activated clotting time (ACT) according to the EN ISO 22870 standards].
    Lasne D; Bauters A; Le Querrec A; Bourdin C; Voisin S; ;
    Ann Biol Clin (Paris); 2015; 73(2):225-54. PubMed ID: 25847747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Our method and concept concerning the activated clotting time (ACT) during cardiopulmonary bypass].
    Watanabe T; Abe T; Iyomasa Y
    Kokyu To Junkan; 1983 Jul; 31(7):781-6. PubMed ID: 6658213
    [No Abstract]   [Full Text] [Related]  

  • 6. Temperature Management Guidelines.
    Hammon JW; Shore-Lesserson L; Dickinson TA
    Ann Thorac Surg; 2015 Aug; 100(2):385. PubMed ID: 26234825
    [No Abstract]   [Full Text] [Related]  

  • 7. Temperature Management Guidelines.
    Hammon JW; Shore-Lesserson L; Dickinson TA
    J Extra Corpor Technol; 2015 Sep; 47(3):144. PubMed ID: 26543247
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrinsic pathway-dependent activated clotting time is not reliable for monitoring anticoagulation during cardiopulmonary bypass in neonates.
    Gu YJ; Huyzen RJ; van Oeveren W
    J Thorac Cardiovasc Surg; 1996 Mar; 111(3):677-8. PubMed ID: 8601987
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiopulmonary bypass machine can interfere with accuracy of BIS monitor.
    Tewari P; Skinner H
    Anesth Analg; 2007 Aug; 105(2):534; author reply 534-5. PubMed ID: 17646520
    [No Abstract]   [Full Text] [Related]  

  • 10. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines for Cardiopulmonary Bypass--Temperature Management during Cardiopulmonary Bypass.
    Engelman R; Baker RA; Likosky DS; Grigore A; Dickinson TA; Shore-Lesserson L; Hammon JW
    J Extra Corpor Technol; 2015 Sep; 47(3):145-54. PubMed ID: 26543248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines for Cardiopulmonary Bypass--Temperature Management During Cardiopulmonary Bypass.
    Engelman R; Baker RA; Likosky DS; Grigore A; Dickinson TA; Shore-Lesserson L; Hammon JW; ; ;
    Ann Thorac Surg; 2015 Aug; 100(2):748-57. PubMed ID: 26234862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of systemic anticoagulation during cardiopulmonary bypass.
    Bidstrup BP
    Ann Thorac Surg; 1996 Mar; 61(3):781-2. PubMed ID: 8619692
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of activated clotting times measured using the Hemochron Jr. Signature and Medtronic ACT Plus during cardiopulmonary bypass with acute normovolemic haemodilution.
    Lee JM; Park EY; Kim KM; Won JC; Jung TK; Lee SK
    J Int Med Res; 2018 Feb; 46(2):873-882. PubMed ID: 28974132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin and heparin monitoring during cardiopulmonary bypass.
    Hunt BJ; Segal H; Yacoub M
    Circulation; 1992 Nov; 86(5 Suppl):II410-2. PubMed ID: 1385011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for monitoring heparin by the activated clotting time when aprotinin is used during cardiopulmonary bypass.
    Hunt BJ; Segal HC; Yacoub M
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):211-2. PubMed ID: 1377315
    [No Abstract]   [Full Text] [Related]  

  • 16. [Should monitoring standards in anesthesia defined by SIAARTI be reconsidered? Yes, but to what extent?].
    Gristina GR
    Minerva Anestesiol; 1998 Mar; 64(3):103-6. PubMed ID: 9677795
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro effect of fresh frozen plasma on the activated coagulation time in patients undergoing cardiopulmonary bypass.
    Barnette RE; Shupak RC; Pontius J; Rao AK
    Anesth Analg; 1988 Jan; 67(1):57-60. PubMed ID: 3257361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation policy during use of aprotinin in cardiopulmonary bypass.
    van Oeveren W; van Oeveren B; Wildevuur CR
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):210-1. PubMed ID: 1377314
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recommendations for basic monitoring of patients during anesthesia. Gruppo di Studio SAARTI per la Sicurezza in Anestesia e Terapia Intensiva].
    Minerva Anestesiol; 1997 Sep; 63(9):267-70. PubMed ID: 9542385
    [No Abstract]   [Full Text] [Related]  

  • 20. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
    Ganter MT; Monn A; Tavakoli R; Klaghofer R; Zollinger A; Hofer CK
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.